CA2332389A1 - Liposomal preparations for the application of antiseptic agents to the interior of the body - Google Patents

Liposomal preparations for the application of antiseptic agents to the interior of the body Download PDF

Info

Publication number
CA2332389A1
CA2332389A1 CA002332389A CA2332389A CA2332389A1 CA 2332389 A1 CA2332389 A1 CA 2332389A1 CA 002332389 A CA002332389 A CA 002332389A CA 2332389 A CA2332389 A CA 2332389A CA 2332389 A1 CA2332389 A1 CA 2332389A1
Authority
CA
Canada
Prior art keywords
interior
application
antiseptic agents
liposomal preparations
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002332389A
Other languages
French (fr)
Other versions
CA2332389C (en
Inventor
Wolfgang Fleischer
Karen Reimer
Axel Kramer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Wolfgang Fleischer
Karen Reimer
Axel Kramer
Euro-Celtique, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wolfgang Fleischer, Karen Reimer, Axel Kramer, Euro-Celtique, S.A. filed Critical Wolfgang Fleischer
Publication of CA2332389A1 publication Critical patent/CA2332389A1/en
Application granted granted Critical
Publication of CA2332389C publication Critical patent/CA2332389C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Use of anti-inflammatory agents such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases of the upper respiratory tract and/or the ear which are susceptible to the administration of such agents.
CA002332389A 1998-05-27 1999-05-27 Liposomal preparations for the application of antiseptic agents to the interior of the body Expired - Lifetime CA2332389C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8689598P 1998-05-27 1998-05-27
US60/086,895 1998-05-27
PCT/EP1999/003677 WO1999060998A1 (en) 1998-05-27 1999-05-27 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear

Publications (2)

Publication Number Publication Date
CA2332389A1 true CA2332389A1 (en) 1999-12-02
CA2332389C CA2332389C (en) 2008-09-09

Family

ID=22201600

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002332389A Expired - Lifetime CA2332389C (en) 1998-05-27 1999-05-27 Liposomal preparations for the application of antiseptic agents to the interior of the body
CA002332369A Abandoned CA2332369A1 (en) 1998-05-27 1999-05-27 Drug delivery system comprising a tightly compacted solid medicament stock
CA002332371A Abandoned CA2332371A1 (en) 1998-05-27 1999-05-27 Preparations for the application of antiseptic agents and/or agents which promote the healing of wounds, to the lower respiratory tract

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA002332369A Abandoned CA2332369A1 (en) 1998-05-27 1999-05-27 Drug delivery system comprising a tightly compacted solid medicament stock
CA002332371A Abandoned CA2332371A1 (en) 1998-05-27 1999-05-27 Preparations for the application of antiseptic agents and/or agents which promote the healing of wounds, to the lower respiratory tract

Country Status (19)

Country Link
US (2) US20080038330A1 (en)
EP (3) EP1079806B1 (en)
JP (3) JP4741726B2 (en)
KR (3) KR100613706B1 (en)
CN (3) CN1303276A (en)
AT (3) ATE235895T1 (en)
AU (3) AU752018C (en)
BR (3) BR9911070A (en)
CA (3) CA2332389C (en)
CY (1) CY1105834T1 (en)
DE (6) DE69906518D1 (en)
DK (2) DK1079807T3 (en)
ES (2) ES2260915T3 (en)
HK (2) HK1035336A1 (en)
HU (3) HU226710B1 (en)
IL (4) IL139230A0 (en)
PT (2) PT1079807E (en)
RU (3) RU2211693C2 (en)
WO (3) WO1999060998A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US7364749B1 (en) 1999-05-27 2008-04-29 Euro-Celtique, S.A. Preparations for the application of anti-infective and/or anti-inflammatory agents

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
AU772314B2 (en) * 1999-05-27 2004-04-22 Euro-Celtique S.A. Preparations for the application of anti-inflammatory agents
HU229705B1 (en) * 2000-02-08 2014-05-28 Euro Celtique Sa Tamper-resistant oral opioid agonist formulations
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
KR100743404B1 (en) 2000-12-21 2007-07-30 넥타르 테라퓨틱스 Pulmonary delivery of polyene antifungal agents
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
DE10125731A1 (en) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Dosage form of immunological agents
DE10141650C1 (en) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate
WO2003077891A1 (en) * 2002-03-18 2003-09-25 Yamanouchi Pharmaceutical Co., Ltd. Powdery medicinal compositions for inhalation and process for producing the same
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
WO2004043473A1 (en) * 2002-11-11 2004-05-27 Kowa Co., Ltd. Composition for restoring damaged skin
WO2004066975A1 (en) 2002-12-18 2004-08-12 Hough Ear Institute Otologic nanotechnology
EP1449520A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-Iodine liposomes for treatment of herpes
ATE371436T1 (en) 2003-05-19 2007-09-15 Euro Celtique Sa DRY LIPOSOMAL PVP-IODINE PREPARATIONS
US8651113B2 (en) 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7723311B2 (en) 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
FR2878746B1 (en) 2004-12-02 2007-02-23 Vetoquinol Sa Sa NOVEL PHARMACEUTICAL COMPOSITION FOR USE IN THE FIELD OF VACCINES
CA2599667C (en) 2005-03-10 2014-12-16 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxy carboxylic acids
KR20070113284A (en) 2005-03-10 2007-11-28 쓰리엠 이노베이티브 프로퍼티즈 캄파니 Methods of reducing microbial contamination
PL1962805T3 (en) 2005-12-08 2017-01-31 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
DE102006011314A1 (en) 2006-03-11 2007-10-18 Peter Dr. Engels Cosmetic preparations containing an additive from the baobab plant
TW200817047A (en) * 2006-04-03 2008-04-16 Teva Pharma Drug microparticles
RU2315593C1 (en) * 2006-08-02 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Antioxidant liposomal composition fir inhalation in lung and upper respiratory tract diseases
US8071127B2 (en) 2006-10-24 2011-12-06 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8119156B2 (en) 2006-10-24 2012-02-21 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
EP2091324B1 (en) 2006-10-27 2016-12-28 3M Innovative Properties Company Antimicrobial compositions
WO2008137717A1 (en) 2007-05-04 2008-11-13 Transave, Inc. Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
EA017359B1 (en) * 2007-11-23 2012-11-30 Фармалунденсис Аб Method and composition for obtaining bronchorelaxation
WO2009085651A1 (en) 2007-12-20 2009-07-09 Nucryst Pharmaceuticals Corp. Metal carbonate particles for use in medicine and methods of making thereof
KR20100048751A (en) * 2008-10-31 2010-05-11 주식회사 동성바이오레인 Capsulated functional dual core aerosol composition and the method for their manufacture
NL2002442C2 (en) 2009-01-22 2010-07-26 Weezenbeek Specialties B V Van Process for rejuvenating a composition containing a compound.
EP2226073A1 (en) 2009-03-02 2010-09-08 Euro-Celtique S.A. Topical pharmaceutical composition comprising an antiseptic and arginine for wound healing
US20110086084A1 (en) * 2009-10-13 2011-04-14 David William Koenig Active Agent Containing Polymer Network Delivery Composition and Articles Using the Same
SI2722053T1 (en) 2010-12-30 2018-02-28 Aktsionernoye Obshchestvo "Nauchnyi Tsentr Protivoninfektsionnyh Preparatov" Antibacterial agent for treating infectious diseases of bacterial origin
US9925251B2 (en) 2011-10-19 2018-03-27 President And Fellows Of Harvard College Treatments for Mycobacterium tuberculosis
KR101860485B1 (en) * 2011-11-03 2018-07-02 (주)아모레퍼시픽 Tissue for skin with nano-emulsion, method for manufacturing the same and method for using the same
JP6402097B2 (en) 2012-05-21 2018-10-10 インスメッド インコーポレイテッド System for treating pulmonary infections
ES2743039T3 (en) 2012-11-29 2020-02-18 Insmed Inc Vancomycin stabilized formulations
RU2538433C1 (en) * 2013-06-11 2015-01-10 Закрытое акционерное общество "ФИРН М" (ЗАО ФИРН М") Pharmaceutical composition for preventing and treating infectious-inflammatory diseases of various origins by oromucosal administration
US9987227B2 (en) 2013-10-22 2018-06-05 Aradigm Corporation Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
RU2550932C1 (en) * 2014-03-18 2015-05-20 Александр Александрович Кролевец Method for producing cephalosporin nanocapsules in xanthum gum
EP3129008A4 (en) * 2014-04-08 2017-09-06 Aradigm Corporation Liposomes that form drug nanocrystals after freeze-thaw
US9532986B2 (en) 2014-04-08 2017-01-03 Aradigm Corporation Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
US20160120806A1 (en) * 2014-04-08 2016-05-05 Aradigm Corporation Nanocrystals formed in a microenvironment
US10238675B2 (en) 2014-05-15 2019-03-26 Insmed Incorporated Methods for treating pulmonary non-tuberculous mycobacterial infections
HUE056533T2 (en) 2014-07-23 2022-02-28 Firebrick Pharma Ltd Treatment and prevention of the common cold using povidone-iodine
KR102086150B1 (en) 2017-04-10 2020-03-06 부산대학교 산학협력단 in situ Hydrogel Forming Powder Composition for Wound Healing, and Method for Preparing thereof
FR3066115B1 (en) 2017-05-10 2019-06-28 Universite de Bordeaux COMPRESSES OF NUCLEIC ACID VECTORS
US20200289552A1 (en) * 2017-07-04 2020-09-17 Fluchem Ltd Solid composition comprising iodine agent and sodium chloride having improved water solubility, and antiviral and antimicrobial composition for eye, oral cavity, nasal cavity or inhalation containing aqueous solution thereof
KR101935250B1 (en) * 2017-07-04 2019-01-04 김대황 Antiviral and antibacterial composition comprising iodide and osmotic tastant for eye, oral cavity, nasal cavity or inhalation
WO2019009630A1 (en) * 2017-07-04 2019-01-10 김대황 Solid composition comprising iodine agent and sodium chloride having improved water solubility, and antiviral and antimicrobial composition for eye, oral cavity, nasal cavity or inhalation containing aqueous solution thereof
KR102026805B1 (en) 2017-12-12 2019-11-04 주식회사 크로파세 A anti-inflammation cosmetic composition
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
WO2019202400A1 (en) * 2018-04-17 2019-10-24 Universite De Caen Normandie Bambuterol for the treatment of alzheimer's disease
RU2730834C1 (en) * 2020-01-17 2020-08-26 Александр Александрович Кролевец Method of producing thymol nanocapsules
WO2021201310A1 (en) * 2020-03-30 2021-10-07 현대바이오사이언스 주식회사 Ethosome composition having vitamin and dexpanthenol encapsulated therein, and preparation method therefor
CN111700883B (en) * 2020-07-23 2021-04-06 深圳大佛药业股份有限公司 Salbutamol sulfate sustained-release inhalation preparation and production process thereof
JP2022151438A (en) * 2021-03-26 2022-10-07 均 石井 Agents for treating conchitis and tympanitis
JP2022151426A (en) * 2021-03-26 2022-10-07 均 石井 Agents for treating upper respiratory inflammation

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615889A (en) * 1952-04-15 1900-01-01
US4113857A (en) * 1977-05-16 1978-09-12 The Purdue Frederick Company Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same
US4675009A (en) * 1977-11-07 1987-06-23 Lec Tec Corporation Drug dispensing device for transdermal delivery of medicaments
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2536278A1 (en) * 1982-11-18 1984-05-25 Dupont Michele NOVEL THERAPEUTIC COMPOSITION USEFUL IN PARTICULAR FOR WOUND HEALING
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
FR2581542B1 (en) * 1985-05-07 1988-02-19 Oreal TOPICAL COMPOSITIONS FOR THE TREATMENT OF SKIN BASED ON SALICYLIC ACID DERIVATIVES
FR2591105B1 (en) * 1985-12-11 1989-03-24 Moet Hennessy Rech PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, OR COSMETIC, BASED ON HYDRATED LIPID LAMELLAR PHASES OR LIPOSOMES CONTAINING A RETINOIDE OR A STRUCTURAL ANALOG OF SUCH A RETINOID AS A CAROTENOID.
SE8603812D0 (en) * 1986-09-12 1986-09-12 Draco Ab ADMINISTRATION OF LIPOSOMES TO MAMMALS
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US4938965A (en) * 1987-07-22 1990-07-03 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Ocular delivery of prophylactic agents
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
DE3826946C1 (en) * 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5232692A (en) * 1989-04-28 1993-08-03 Research And Education Institute, Inc. Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
DE407028T1 (en) * 1989-05-31 1994-03-17 Fisons Plc Medicament and inhalation device therefor.
US5089389A (en) * 1989-08-25 1992-02-18 Eastman Kodak Company Buffered composition, coated article test device and a method for their use
US5128139A (en) * 1991-02-15 1992-07-07 Nu Skin International, Inc. Composition containing liposome-entrapped grapefruit seed extract and method for making
DE4111982C2 (en) * 1991-04-12 1998-12-24 Merz & Co Gmbh & Co Stable small particulate liposome preparations, their preparation and use
EP0580860B2 (en) * 1991-04-16 2004-12-15 Nippon Shinyaku Company, Limited Method of manufacturing solid dispersion
JPH06507404A (en) * 1991-05-01 1994-08-25 ヘンリー　エム．ジャクソン　ファウンデイション　フォー　ザ　アドバンスメント　オブ　ミリタリー　メディスン How to treat infectious respiratory diseases
AU4066693A (en) * 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
US5552158A (en) * 1993-02-23 1996-09-03 Norac Technologies Inc. Skin care composition
DE4306475A1 (en) * 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomes containing chlorhexidine diacetate or chlorhexidine digluconate
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5456904A (en) * 1993-06-28 1995-10-10 The Procter & Gamble Company Photoprotection compositions comprising certain chelating agents
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
DE9312509U1 (en) * 1993-08-20 1993-10-28 Euro Celtique Sa Preparations for external administration of antiseptic and / or wound healing promoting agents
BR9509590A (en) * 1994-11-04 1997-12-23 Polymun Scient Immunbio Forsch Application of sod in liposomes
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
JPH08301774A (en) * 1995-05-08 1996-11-19 Kowa Co Throat disinfectant
WO1998055104A1 (en) * 1997-06-06 1998-12-10 Shionogi & Co., Ltd. Improvement in medicament administration system
MXPA01012169A (en) * 1999-05-27 2002-06-21 Euro Celtique Sa Preparations for the application of anti-infective and/or anti-inflammatory agents.
US7300667B1 (en) * 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
AU772314B2 (en) * 1999-05-27 2004-04-22 Euro-Celtique S.A. Preparations for the application of anti-inflammatory agents
US7297344B1 (en) * 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US6497896B2 (en) * 2001-02-12 2002-12-24 Supergen, Inc. Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
ATE371436T1 (en) * 2003-05-19 2007-09-15 Euro Celtique Sa DRY LIPOSOMAL PVP-IODINE PREPARATIONS
US8435261B2 (en) * 2009-07-15 2013-05-07 Regents Of The University Of Minnesota Treatment and placement device for sinusitis applications

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US7364749B1 (en) 1999-05-27 2008-04-29 Euro-Celtique, S.A. Preparations for the application of anti-infective and/or anti-inflammatory agents

Also Published As

Publication number Publication date
KR20010043820A (en) 2001-05-25
ATE339187T1 (en) 2006-10-15
CY1105834T1 (en) 2011-02-02
PT1079806E (en) 2006-06-30
DE69930259D1 (en) 2006-05-04
DE29923848U1 (en) 2001-04-12
PT1079807E (en) 2007-01-31
DE29923847U1 (en) 2001-04-12
HUP0102892A3 (en) 2002-12-28
HUP0102892A2 (en) 2002-03-28
IL139230A (en) 2007-07-24
AU4266799A (en) 1999-12-13
AU752018B2 (en) 2002-09-05
KR100445146B1 (en) 2004-08-18
KR20010043821A (en) 2001-05-25
DE69933208T2 (en) 2007-08-30
ES2260915T3 (en) 2006-11-01
IL139231A0 (en) 2001-11-25
RU2212884C2 (en) 2003-09-27
WO1999061003A1 (en) 1999-12-02
DE29923766U1 (en) 2001-06-07
HUP0102337A3 (en) 2002-12-28
JP2002516266A (en) 2002-06-04
WO1999060999A1 (en) 1999-12-02
AU759264B2 (en) 2003-04-10
EP1079806A1 (en) 2001-03-07
BR9911070A (en) 2001-02-06
CA2332371A1 (en) 1999-12-02
RU2211693C2 (en) 2003-09-10
KR100613706B1 (en) 2006-08-21
EP1079806B1 (en) 2006-03-08
US20120009253A1 (en) 2012-01-12
AU752018C (en) 2003-10-09
DK1079807T3 (en) 2007-01-22
JP4741727B2 (en) 2011-08-10
DE69930259T2 (en) 2006-11-23
CN1303272A (en) 2001-07-11
AU747877B2 (en) 2002-05-30
HK1035335A1 (en) 2001-11-23
BR9911071A (en) 2001-02-06
EP1079807B1 (en) 2006-09-13
JP4741726B2 (en) 2011-08-10
ATE235895T1 (en) 2003-04-15
AU4370499A (en) 1999-12-13
US20080038330A1 (en) 2008-02-14
KR20010043819A (en) 2001-05-25
CN1303276A (en) 2001-07-11
AU4370699A (en) 1999-12-13
HU226710B1 (en) 2009-07-28
EP1079807A1 (en) 2001-03-07
HK1035336A1 (en) 2001-11-23
IL139229A0 (en) 2001-11-25
IL139230A0 (en) 2001-11-25
BR9911072A (en) 2001-02-06
CA2332389C (en) 2008-09-09
DE69906518D1 (en) 2003-05-08
JP2002516265A (en) 2002-06-04
JP2002516269A (en) 2002-06-04
EP1083886B1 (en) 2003-04-02
CA2332369A1 (en) 1999-12-02
HUP0102899A3 (en) 2002-12-28
CN1303271A (en) 2001-07-11
ATE319427T1 (en) 2006-03-15
HUP0102337A2 (en) 2002-03-28
RU2202340C2 (en) 2003-04-20
HU226729B1 (en) 2009-08-28
HUP0102899A2 (en) 2002-03-28
DK1079806T3 (en) 2006-07-17
ES2273493T3 (en) 2007-05-01
WO1999060998A1 (en) 1999-12-02
EP1083886A1 (en) 2001-03-21
DE69933208D1 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
CA2332389A1 (en) Liposomal preparations for the application of antiseptic agents to the interior of the body
HK1073252A1 (en) Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention or treatment of inflammations in the interior of the human body
CA2389235A1 (en) Controlled release hydrocodone formulations
AU7031500A (en) Therapeutic quinazoline compounds
AU3469400A (en) Pharmaceutical compositions for treatment of diseased tissues
EP1180017B8 (en) Preparations with povidon iodine for wound treatment
AU2001258395A1 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
PL330768A1 (en) Perpetration for use in therapy and prophylactics of dermatological diseases
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
WO2001028535A3 (en) Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate
AU2002253785A1 (en) Catheter and implants for the delivery of therapeutic agents to tissues
GEP20043377B (en) Pharmaceutical Complex
CA2370501A1 (en) Pharmaceutical composition for the therapy of lower urinary tract symptoms
AU5424600A (en) Antiseptic and antimicrobial pharmaceutical preparation of feracrylum
AU7455300A (en) The band combined medical treatment of ion
AU2002234617A1 (en) Cosmetic or pharmaceutical preparations of the treatment of epithelial outer tissue
AU1007401A (en) Treatment of respiratory diseases and infections

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20190527